Yayın: Novel Thiazole-Hydrazide Derivatives and Their Anticancer Properties
| dc.contributor.author | KARADUMAN, ABDULLAH BURAK | |
| dc.contributor.author | YURTTAŞ, LEYLA | |
| dc.contributor.author | Sam Dawbaa | |
| dc.contributor.author | Abdullah Burak Karaduman | |
| dc.contributor.author | Leyla Yurttaş | |
| dc.contributor.orcid | 0000-0002-8651-826X | |
| dc.contributor.orcid | 0000-0002-7271-6791 | |
| dc.contributor.orcid | 0000-0001-7001-0739 | |
| dc.contributor.orcid | 0000-0002-0434-1334 | |
| dc.contributor.orcid | 0000-0002-0957-6044 | |
| dc.date.accessioned | 2025-11-13T12:08:41Z | |
| dc.date.issued | 2024-09-09 | |
| dc.identifier.doi | https://doi.org/10.33808/clinexphealthsci.1414252 | |
| dc.identifier.endpage | 789 | |
| dc.identifier.issn | 2459-1459 | |
| dc.identifier.issue | 3 | |
| dc.identifier.openalex | W4402349395 | |
| dc.identifier.startpage | 783 | |
| dc.identifier.uri | https://hdl.handle.net/11421/9100 | |
| dc.identifier.uri | https://doi.org/10.33808/clinexphealthsci.1414252 | |
| dc.identifier.volume | 14 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Clinical and Experimental Health Sciences | |
| dc.rights | openAccess | |
| dc.subject | Cytotoxicity | |
| dc.subject | Thiazole | |
| dc.subject | A549 cell | |
| dc.subject | Lung cancer | |
| dc.subject | Hydrazide | |
| dc.subject | Pharmacology | |
| dc.subject | Drug | |
| dc.subject | Cancer cell | |
| dc.subject | Paclitaxel | |
| dc.subject | Cancer research | |
| dc.subject | Chemistry | |
| dc.subject | Medicine | |
| dc.subject | Cancer | |
| dc.subject | Stereochemistry | |
| dc.subject | Biochemistry | |
| dc.subject | In vitro | |
| dc.subject | Oncology | |
| dc.subject | Internal medicine | |
| dc.subject | Organic chemistry | |
| dc.subject.sdg | 3 | |
| dc.title | Novel Thiazole-Hydrazide Derivatives and Their Anticancer Properties | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5030295748 | |
| local.authorid.openalex | A5090129265 |
